MTOR and hepatocellular carcinoma: In addition, we reveal that MELK enhanced the levels of the CRS gene DLAT by activation of the PI3K/mTOR signaling pathway, thereby promoting the elesclomol drug-resistant and altering mitochondrial function and ultimately accelerating the progression of HCC.